Autologous Dendritic Cell Therapy in Mesothelioma Patients Enhances Frequencies of Peripheral CD4 T Cells Expressing HLA-DR, PD-1, or ICOS

Introduction: Malignant pleural mesothelioma (MPM) is a malignancy with a very poor prognosis for which new treatment options are urgently needed. We have previously shown that dendritic cell (DC) immunotherapy provides a clinically feasible treatment option. In the current study, we set out to asse...

Descripción completa

Detalles Bibliográficos
Autores principales: de Goeje, Pauline L., Klaver, Yarne, Kaijen-Lambers, Margaretha E. H., Langerak, Anton W., Vroman, Heleen, Kunert, André, Lamers, Cor H. J., Aerts, Joachim G. J. V., Debets, Reno, Hendriks, Rudi W.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2018
Materias:
Immunology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6137618/
https://www.ncbi.nlm.nih.gov/pubmed/30245692
http://dx.doi.org/10.3389/fimmu.2018.02034

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6137618/
https://www.ncbi.nlm.nih.gov/pubmed/30245692
http://dx.doi.org/10.3389/fimmu.2018.02034

Ejemplares similares